FDA revises drug broadcast rules

被引：0

|

作者：

不详

机构：

来源：

NATURE MEDICINE | 1997年 / 3卷 / 09期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：940 / 940

页数：1

相关论文

共 50 条

[1] FDA revises drug broadcast rules
Karen Birmingham
Nature Medicine, 1997, 3 (9) : 940 - 940
[2] FDA revises process for responding to Drug Applications
不详
GASTROENTEROLOGY, 2008, 135 (03) : 721 - 721
[3] US FDA revises prescription drug information format
Reactions Weekly, 2006, 1086 (1) : 3 - 3
[4] FDA revises drug. review nomenclature, process
不详
FORMULARY, 2004, 39 (09) : 461 - 461
[5] FDA revises drug labels to clarify information for health professionals
Wechsler, J
FORMULARY, 2006, 41 (03) : 162 - 163
[6] FDA revises definition of "no residue"
不详
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2003, 222 (03): : 273 - 273
[7] Congress Revises Rules for Drug Compounding and Supply-Chain Security
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2013, 26 (11) : 8 - 9
[8] The FDA revises requirements for levothyroxine products
Burman, Kenneth
Hennessey, James
McDermott, Michael
Wartofsky, Leonard
Emerson, Charles
THYROID, 2008, 18 (05) : 487 - 490
[9] US FDA revises labelling for PPIs
Reactions Weekly, 2010, 1304 (1) : 2 - 2
[10] NIH revises conflict rules
Agres T.
Genome Biology, 4 (1)

← 1 2 3 4 5 →